FK506 Phase 4 Study: A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients
Phase of Trial: Phase IV
Latest Information Update: 15 Oct 2014
At a glance
- Drugs Tacrolimus (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 09 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 27 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2008 Patient numbers amended from 120 to 123 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History